U.S. health insurer Humana Inc. and two private equity firms agreed to buy home healthcare and long-term care operator Kindred Healthcare Inc. for about $810 million, the latest expansion by an American health insurer into patient care.

Teva Pharmaceutical Industries Ltd. is close to a deal to sell its women’s health assets outside the United States to private equity firm CVC Capital Partners, the Fly reported, citing Bloomberg.

The hope of new measures for the FDA to advance the regulatory path for drug development is forging ahead incorporating relatively swift pivotal data in seeking accelerated approvals.

The EQT VII fund announced that it has agreed to acquire Certara, the leading provider of technology-driven decision support solutions for drug development, for an enterprise value of $850 million.

The Carlyle Group and GTCR LLC are acquiring contract research organization Albany Molecular Research (AMRI) for about $922 million in cash.

INC Research Holdings, a contract research organization, is buying Boston, Mass.-based CRO inVentiv Health. The two companies have inked a definitive merger agreement that values inVentiv at an enterprise value of about $4.6 billion.

International private equity firm Cinven announced a deal to acquire Bioclinica, a global provider of clinical trial services and technology to contract research organizations and pharmaceutical companies, from Water Street Healthcare Partners and JLL Partners.

Drug distributor AmerisourceBergen Corp agreed to buy PharMEDium Healthcare Holdings Inc for $2.58 billion from private equity firm Clayton, Dubilier & Rice, expanding its business of supplying compounded drugs to hospitals. Compounding is a process in which pharma products are diluted to create doses that are not sold commercially. Increased regulatory oversight following a fungal […]